Ono Pharmaceutical Co. (OPHLY)
Healthcare · Drug Manufacturers - General
1 member of Congress has disclosed 1 trade in Ono Pharmaceutical Co. (OPHLY) since 2023: 0 buys and 1 sale. The most recent was disclosed on Aug 13, 2023.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 0 / 1
- Reported value
- $1K–$15K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at OPHLY
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
OPHLY: third_quarter 2026 lobbying report
Monitor administrative and legislative action affecting FDA drug approvals
Public: Oct 19, 2026, 8:38 AM EDTOriginal source ↗OPHLY: second_quarter 2026 lobbying report
Monitor administrative and legislative action affecting FDA drug approvals
Public: Jul 20, 2026, 9:30 AM EDTOriginal source ↗
Who traded OPHLY
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01Aug 13, 2023
All trades
- Aug 13, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold Ono Pharmaceutical Co. OPHLY
$1K–$15K · Traded Jul 10, 2023 · disclosed Aug 13, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.